NO146711C - Analogifremgangsmaate for fremstilling av oleandomycin- og erytromycinderivater. - Google Patents

Analogifremgangsmaate for fremstilling av oleandomycin- og erytromycinderivater.

Info

Publication number
NO146711C
NO146711C NO790006A NO790006A NO146711C NO 146711 C NO146711 C NO 146711C NO 790006 A NO790006 A NO 790006A NO 790006 A NO790006 A NO 790006A NO 146711 C NO146711 C NO 146711C
Authority
NO
Norway
Prior art keywords
oleandomycin
preparation
erythromycin derivatives
analogy procedure
analogy
Prior art date
Application number
NO790006A
Other languages
English (en)
Norwegian (no)
Other versions
NO790006L (no
NO146711B (no
Inventor
Frank C Sciavolino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO790006L publication Critical patent/NO790006L/no
Publication of NO146711B publication Critical patent/NO146711B/no
Publication of NO146711C publication Critical patent/NO146711C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO790006A 1978-01-03 1979-01-02 Analogifremgangsmaate for fremstilling av oleandomycin- og erytromycinderivater. NO146711C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86672278A 1978-01-03 1978-01-03
US05/937,640 US4180654A (en) 1978-01-03 1978-08-29 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate

Publications (3)

Publication Number Publication Date
NO790006L NO790006L (no) 1979-07-04
NO146711B NO146711B (no) 1982-08-16
NO146711C true NO146711C (no) 1982-11-24

Family

ID=27127966

Family Applications (2)

Application Number Title Priority Date Filing Date
NO790006A NO146711C (no) 1978-01-03 1979-01-02 Analogifremgangsmaate for fremstilling av oleandomycin- og erytromycinderivater.
NO820613A NO147716C (no) 1978-01-03 1982-02-26 Analogifremgangsmaate for fremstilling av antibakterielle erytromycylaminderivater.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO820613A NO147716C (no) 1978-01-03 1982-02-26 Analogifremgangsmaate for fremstilling av antibakterielle erytromycylaminderivater.

Country Status (28)

Country Link
US (1) US4180654A (ar)
JP (1) JPS5495585A (ar)
AT (1) AT364457B (ar)
AU (1) AU506684B2 (ar)
CH (1) CH639972A5 (ar)
CS (1) CS204042B2 (ar)
DD (1) DD141026A5 (ar)
DE (2) DE2953969C2 (ar)
DK (1) DK147943C (ar)
ES (2) ES476544A1 (ar)
FI (1) FI68058C (ar)
FR (1) FR2413403A1 (ar)
GB (1) GB2013181B (ar)
GR (1) GR72779B (ar)
HU (1) HU180276B (ar)
IE (1) IE47642B1 (ar)
IL (1) IL56363A (ar)
IN (1) IN150395B (ar)
IT (1) IT1109925B (ar)
LU (1) LU80747A1 (ar)
NL (1) NL176461C (ar)
NO (2) NO146711C (ar)
NZ (1) NZ189274A (ar)
PH (4) PH14745A (ar)
PL (2) PL118573B1 (ar)
PT (1) PT69014A (ar)
SE (2) SE447118B (ar)
YU (2) YU312278A (ar)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6211669Y2 (ar) * 1980-10-06 1987-03-19
JPS5848285U (ja) * 1981-09-26 1983-04-01 コナミ工業株式会社 テ−ブル型テレビゲ−ム機
US4429116A (en) * 1982-12-27 1984-01-31 Pfizer Inc. Alkylated oleandomycin containing compounds
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
JPS62240086A (ja) * 1986-04-12 1987-10-20 株式会社　エ−ス電研 遊技機の前面構造
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
YU55690A (en) * 1990-03-21 1990-12-31 Pliva Pharm & Chem Works Process for preparing oleandomycin oxime
JP2006528667A (ja) * 2003-05-13 2006-12-21 グラクソ　グループ　リミテッド 新規１４−及び１５−員環化合物
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310992D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869445A (en) * 1973-05-03 1975-03-04 Abbott Lab 4{41 -O-sulfonyl erythromycin-9-O-oxime derivatives
US3884902A (en) * 1973-05-04 1975-05-20 Abbott Lab Sulfonyl derivatives of erythromycin
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives
US4063014A (en) * 1975-06-12 1977-12-13 Abbott Laboratories 4"-O-sulfonyl erythromycin-9-O-oxime derivatives
IE44509B1 (en) * 1976-03-03 1981-12-30 Pfizer Semi-synthetic oleandomycins
US4069379A (en) * 1976-07-08 1978-01-17 Pfizer Inc. Semi-synthetic oleandomycins
US4085119A (en) * 1977-02-04 1978-04-18 Pfizer Inc. 4-Substituted amino derivatives of oleandomycin
US4090017A (en) * 1977-02-04 1978-05-16 Pfizer Inc. 4-Deoxy-4-substituted amino derivatives of oleandomycin

Also Published As

Publication number Publication date
JPS5495585A (en) 1979-07-28
SE448385B (sv) 1987-02-16
NO147716B (no) 1983-02-21
SE8304417L (sv) 1983-08-15
YU312278A (en) 1983-01-21
AU506684B2 (en) 1980-01-17
IT7919013A0 (it) 1979-01-02
IT1109925B (it) 1985-12-23
DD141026A5 (de) 1980-04-09
GR72779B (ar) 1983-12-05
DE2953969C2 (ar) 1987-09-03
JPS5734280B2 (ar) 1982-07-22
PH15439A (en) 1983-01-18
PL118573B1 (en) 1981-10-31
ES482420A1 (es) 1980-09-01
SE8304417D0 (sv) 1983-08-15
NZ189274A (en) 1982-03-23
ATA2979A (de) 1981-03-15
NO790006L (no) 1979-07-04
GB2013181A (en) 1979-08-08
DK507778A (da) 1979-07-04
GB2013181B (en) 1982-06-03
AT364457B (de) 1981-10-27
IL56363A0 (en) 1979-03-12
NL7900006A (nl) 1979-07-05
AU4298578A (en) 1979-07-12
SE7900028L (sv) 1979-07-04
CH639972A5 (de) 1983-12-15
IE47642B1 (en) 1984-05-16
FR2413403A1 (fr) 1979-07-27
PL117603B1 (en) 1981-08-31
SE447118B (sv) 1986-10-27
PH15752A (en) 1983-03-18
NO147716C (no) 1983-06-01
FR2413403B1 (ar) 1982-07-23
FI790004A (fi) 1979-07-04
US4180654A (en) 1979-12-25
IL56363A (en) 1982-12-31
DE2900118A1 (de) 1979-07-05
DK147943C (da) 1985-08-05
YU213982A (en) 1983-02-28
NO820613L (no) 1979-07-04
LU80747A1 (fr) 1979-09-07
ES476544A1 (es) 1979-12-01
CS204042B2 (en) 1981-03-31
IN150395B (ar) 1982-09-25
PH15626A (en) 1983-03-11
NO146711B (no) 1982-08-16
HU180276B (en) 1983-02-28
DK147943B (da) 1985-01-14
PT69014A (en) 1979-02-01
FI68058B (fi) 1985-03-29
DE2900118C2 (ar) 1987-09-17
PL212593A1 (pl) 1979-08-27
IE790005L (en) 1979-07-03
NL176461C (nl) 1985-04-16
FI68058C (fi) 1985-07-10
PH14745A (en) 1981-11-20

Similar Documents

Publication Publication Date Title
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
NO821087L (no) Fremgangsmaate for fremstilling av cyklobutan-derivater.
NO152935C (no) Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater.
NO791831L (no) Fremgangsmaate for fremstilling av aminotiazoler
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
NL190755B (nl) Werkwijze ter bereiding van het D-kamferaat van L-carnitinamide en het D-kamferaat van D-carnitinamide.
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
NO146711C (no) Analogifremgangsmaate for fremstilling av oleandomycin- og erytromycinderivater.
NO834236L (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater
NO150799C (no) Fremgangsmaate for fremstilling av lysergol-derivater
NO155693C (no) Fremgangsmaate for fremstilling av eburnamoninderivater.
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
NO811628L (no) Fremgangsmaate for fremstilling av karbapenam- og karbapen-2-em-derivater.
NO145955C (no) Analogifremgangsmaate for fremstilling av oleandomycin-derivater
SE7804878L (sv) Forfarande for framstellning av 1,2-dikloretan
NO152840C (no) Fremgangsmaate for fremstilling av dibenzyletere.
NO793164L (no) Fremgangsmaate for fremstilling av natriumamoksycillan
NO146472C (no) Analogifremgangsmaate for fremstilling av erytromycin-derivater
NO158736C (no) Analogifremgangsmaate for fremstilling av tetrahydropyridinderivater.
NO803115L (no) Fremgangsmaate for fremstilling av stivelselim
NO152254C (no) Fremgangsmaate til fremstilling av karbazolderivater
NO794090L (no) Fremgangsmaate for fremstilling av klordioksyd
SE7709402L (sv) Forfarande for framstellning av tetrahydropyridinderivat
NO153688C (no) Fremgangsmaate for fremstilling av 2-isopropylaminopyrimidin.
DK1579A (da) Fremgangsmaade til fremstilling af 11-alkanoyl-4"-deoxy-4"-isonitrilo-oleandomycenderivater